MapLight Therapeutics (NAS: MPLT)

Burlington, MA · Founded 2018 · Publicly Held

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. MapLight Therapeutics (NAS: MPLT) is based in Burlington, MA and was founded in 2018. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $704 million (Oct 2025). It has raised $919 million.

Last price · $/share

—

Implied valuation

$704.3M

Total raised

$919.4M

Last round

—

How much has MapLight Therapeutics (NAS: MPLT) raised?

$919.4Macross 0 recorded rounds

Free account

More of MapLight Therapeutics (NAS: MPLT) with a free account

·Watch MapLight Therapeutics (NAS: MPLT): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MapLight Therapeutics (NAS: MPLT) investors

2 investors are on record for MapLight Therapeutics (NAS: MPLT), including Novo Holdings and The Goldman Sachs Group.

For fundraisers

Raising for a company like MapLight Therapeutics (NAS: MPLT)?

2 investors have backed MapLight Therapeutics (NAS: MPLT).

See all 2 investors →

Frequently asked about MapLight Therapeutics (NAS: MPLT)

How much has MapLight Therapeutics (NAS: MPLT) raised?: MapLight Therapeutics (NAS: MPLT) has raised $919.4M in total across 0 recorded funding rounds.